Suppr超能文献

垂体特异转录因子引入后无功能促肾上腺皮质腺瘤的临床影像学分析。

A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors.

机构信息

Department of Neurosurgery, Christian Medical College, Vellore, 632004, India.

Department of Endocrinology, Christian Medical College, Vellore, India.

出版信息

Acta Neurochir (Wien). 2021 Nov;163(11):3143-3154. doi: 10.1007/s00701-021-04911-2. Epub 2021 Jun 28.

Abstract

BACKGROUND

Silent corticotroph adenomas (SCAs) are a rare subtype of non-functional pituitary adenoma. While it has been suggested that they are more aggressive and recur more frequently following excision, there is limited literature on the optimum treatment strategy for these tumors, especially regarding the role of radiation therapy in incompletely resected tumors.

METHOD

We assimilated data from 62 SCAs and 238 other non-functional adenomas (ONAs), defined according to the WHO 2017 criteria that incorporates transcription factor analysis. We compared their clinicoradiological characteristics, such as hormonal levels, tumor configuration, size, and invasiveness. For 52 SCAs and 205 ONAs with serial follow-up imaging, we studied outcomes for progression after subtotal resection with or without radiation therapy or recurrence after gross total resection. Kaplan Meier analysis for recurrence or progression was used to determine the need for a differential treatment strategy for SCAs compared with other non-functional adenomas specifically concerning the role of radiotherapy.

RESULTS

Patients with SCAs present at a younger age than ONAs (43.9 years vs. 48.2 years, p = 0.014), with larger (14.9 cc vs. 9.7 cc, p = 0.006) and more invasive adenomas (61.2% vs. 45.8%, p = 0.021). Overall, SCAs are more likely to recur or progress (48.7 vs. 15.7%, p < 0.001) following excision than ONAs, with significantly poorer event-free survival (Log rank test p < 0.001). Early adjuvant radiotherapy provides favorable outcomes among SCAs with postoperative residual tumor, on par with ONAs. Multivariate analysis identified male gender (HR: 2.217; p = 0.017), MIB index ≥ 3% (HR: 2.116; p = 0.012), and SCA tumor pathology (HR: 3.787; p < 0.001) as factors predicting recurrence.

CONCLUSIONS

Based on the results of this retrospective, single-center review of 300 non-functional adenomas, we conclude that silent corticotroph adenomas are an aggressive subtype of non-functional pituitary adenomas that are larger, more likely to be invasive, and tend to recur more frequently after a subtotal excision compared with other non-functional adenomas. A gross total resection must be attempted whenever possible and earlier adjuvant radiation is recommended when re-surgery for residual tumor is difficult.

摘要

背景

静默型促肾上腺皮质激素腺瘤(SCAs)是一种罕见的无功能性垂体腺瘤亚型。虽然有研究表明,SCAs 在切除后更具侵袭性且更常复发,但关于这些肿瘤的最佳治疗策略,尤其是关于放疗在不完全切除肿瘤中的作用的文献有限。

方法

我们整合了根据 2017 年 WHO 标准(纳入转录因子分析)定义的 62 例 SCA 和 238 例其他无功能性腺瘤(ONAs)的数据。我们比较了它们的临床影像学特征,如激素水平、肿瘤形态、大小和侵袭性。对于 52 例 SCA 和 205 例 ONAs 的连续随访影像学资料,我们研究了次全切除后是否联合放疗或全切除后复发的进展情况。Kaplan-Meier 分析用于评估复发或进展的情况,以确定与其他无功能性腺瘤相比,SCA 是否需要采用不同的治疗策略,特别是关于放疗的作用。

结果

与 ONAs 相比,SCA 患者的发病年龄更小(43.9 岁 vs. 48.2 岁,p=0.014),肿瘤更大(14.9cc vs. 9.7cc,p=0.006)且侵袭性更强(61.2% vs. 45.8%,p=0.021)。总体而言,与 ONAs 相比,SCA 在切除后更有可能复发或进展(48.7% vs. 15.7%,p<0.001),无事件生存率显著较差(对数秩检验 p<0.001)。对于术后残留肿瘤的 SCA,早期辅助放疗可提供良好的结局,与 ONAs 相当。多因素分析确定男性(HR:2.217;p=0.017)、MIB 指数≥3%(HR:2.116;p=0.012)和 SCA 肿瘤病理学(HR:3.787;p<0.001)是预测复发的因素。

结论

基于这项对 300 例无功能性腺瘤进行的回顾性、单中心研究的结果,我们得出结论,静默型促肾上腺皮质激素腺瘤是一种侵袭性更强的无功能性垂体腺瘤亚型,与其他无功能性腺瘤相比,其体积更大、更具侵袭性,且在次全切除后更常复发。只要可能,必须尝试进行全切除,并且当再次手术切除残留肿瘤困难时,建议早期辅助放疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验